Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2000

View Archived Issues

Safety of clopidogrel shown to be superior to ticlopidine after coronary stenting

Smoking linked to increased TF expression in atherosclerotic plaques

Anadys signs antifungal collaboration with Pharmacia

McGill University licenses fungal genomics technology to Mycota Biosciences

Avanir forms subsidiary to exploit human MAb technology

CuraGen and Abgenix select 24 antibody drug targets for cancer indications

Bioniche reports preclinical findings for MCC in prostate cancer

Copernicus Therapeutics awarded SBIR grant to develop episomal vectors for breast cancer therapy

Therapies aimed at reducing free radicals may innovate treatment of septic shock

Research associates synapsins with cyclosporine-induced hypertension

Researchers establish the effect of beta-blocker nebivolol on nitric oxide production

Antiretroviral therapy reduces but does not eliminate seminal HIV shedding

Medicis obtains rights to Corixa's psoriasis product PVAC

MCA lifts clinical hold on Vasomax

Positive phase II results reported for IoGen in FBD

United submits first sections of Uniprost NDA to FDA for pulmonary hypertension

Genetic sequence of cholera bacterium published

Antineoplastic agents under development at Merck & Co.

New compounds interacting with glutathione reductase useful for cataracts, etc.

New compounds under development at BioChem Pharma for treatment of antiviral infections

Fujisawa receives patent for imidazole agents

Novel thrombin inhibitors under study at LG Chemical

Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers

Novel series of group II mGlu receptor agonists described at ACS meeting

deCODE Genetics and Roche reach milestone in Alzheimer's research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...